New: Our latest case study on qFibrosis' role in the successful development of Rezdiffra


Webcast: Fit-for-purpose: The Evolving Role of Liver Biopsies in MASH Clinical Trials and Patient Management

[Full Podcast] Episode 2 with Dr. David Kleiner feat. Dr Dean Tai - Dialogues on AI Digital Pathology

Date: 13 Oct 2020

In Episode 2 of Dialogues on Digital Pathology, we speak to Dr. David Kleiner, Senior Research Physician and Chief of Post-mortem Section, Laboratory of Pathology, from the Center for Cancer Research at the National Cancer Institute. 

Dr. Kleiner will be sharing his views on AI digital pathology and how it can work hand-in-hand with liver pathologists to empower NASH drug development and clinical practice. During the Q&A segment, Dr. Kleiner will be joined by supporting guest, Dr. Dean Tai, Chief Scientific Officer of HistoIndex, who will provide his insights on the role of machine learning in reinforcing important diagnostic decisions for NASH.